{
    "clinical_study": {
        "@rank": "152871", 
        "arm_group": [
            {
                "arm_group_label": "Hypoxia", 
                "arm_group_type": "Experimental", 
                "description": "Inhaling hypoxic gas mixture to induce hypoxemia during recordings of diameter changes of retinal vessels. Recording are performed during hypoxia alone and in combination with the associated interventions at two examination days."
            }, 
            {
                "arm_group_label": "Normoxia", 
                "arm_group_type": "Experimental", 
                "description": "Breathing atmospheric air during recordings of diameter changes of retinal vessels. Recording are performed during normoxia alone and in combination with the associated interventions at two examination days."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective is to study if an inhibition of nitric oxide and/or prostaglandins\n      affect the diameter changes of retinal vessels observed during hypoxia. Diameter changes are\n      studied using the Dynamic Vessel Analyzer."
        }, 
        "brief_title": "Diameter Changes of Retinal Vessels During Hypoxia", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Diabetes Mellitus Type 1", 
            "Retinal Branch Vein Occlusion"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1", 
                "Anoxia", 
                "Retinal Vein Occlusion"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diabetes type 1 without retinopathy\n\n          -  Retinal branch vein occlusion\n\n        Exclusion Criteria:\n\n          -  Cardio-vascular disease\n\n          -  Lung disease\n\n          -  Pregnancy\n\n          -  Previous ocular disease other than retinal branch vein occlusion\n\n          -  Previous treatment with medications influencing on the intraocular pressure or the\n             metabolism of nitric oxide or prostaglandins"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01689090", 
            "org_study_id": "HypNOCOX"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Hypoxia", 
                    "Normoxia"
                ], 
                "description": "Administration of 1 drop voltaren 45 minutes before recordings of diameter changes of retinal vessels are initiated", 
                "intervention_name": "COX inhibitor", 
                "intervention_type": "Other", 
                "other_name": "Eye drops voltaren 1 mg/ml"
            }, 
            {
                "arm_group_label": [
                    "Hypoxia", 
                    "Normoxia"
                ], 
                "description": "Intravenous administration of L-NMMA during recordings of diameter changes of retinal vessels", 
                "intervention_name": "L-NG-monomethyl arginine citrate", 
                "intervention_type": "Other", 
                "other_name": "L-NMMA"
            }, 
            {
                "arm_group_label": [
                    "Hypoxia", 
                    "Normoxia"
                ], 
                "description": "Combination of interventions. Administration of an eye drop voltaren and 45 minutes later infusion with L-NMMA is started and recording of diameter changes of retinal vessels is performed", 
                "intervention_name": "COX inhibitor + L-NG-monomethyl arginine citrate", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Citric Acid", 
                "Diclofenac", 
                "Cyclooxygenase Inhibitors", 
                "Omega-N-Methylarginine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8000"
                }, 
                "name": "Department of Ophthalmology, Aarhus University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Diameter Changes of Retinal Vessels During Hypoxia", 
        "overall_contact": {
            "last_name": "Line Pedersen, MD", 
            "phone": "+45 78463250"
        }, 
        "overall_official": {
            "affiliation": "Aarhus University Hospital", 
            "last_name": "Line Pedersen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: The Regional Committee on Biomedical Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparing the differences of diameter changes occuring during each of the interventions.", 
            "measure": "Diameter changes of retinal vessels", 
            "safety_issue": "No", 
            "time_frame": "Examination day 1 and 2"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01689090"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Aarhus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}